<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="preparation" /><meta name="keywords" content="Neostigmine: anaesthesia: glycopyrronium bromide with; Glycopyrronium bromide: neostigmine with" /><meta name="IX" content="Neostigmine: anaesthesia: glycopyrronium bromide with; Glycopyrronium bromide: neostigmine with" /><title>Glycopyrronium–Neostigmine: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="265/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="35091.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="203951.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="203951.htm#pB" title="Skip Navigation">Skip Navigation</a><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=203951.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 26 May 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF No. 63 (March 2012)</a> &gt; <a href="2082.htm">15 Anaesthesia</a> &gt; <a href="6559.htm">15.1 General anaesthesia</a> &gt; <a href="6666.htm">15.1.6 Drugs for reversal of neuromuscular blockade</a> &gt; <a href="201172.htm">Anticholinesterases</a> &gt; <a href="203950.htm">NEOSTIGMINE WITH GLYCOPYRRONIUM BROMIDE</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="6669.htm" title="Previous: NEOSTIGMINE METILSULFATE">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="201173.htm" title="Next: Other drugs for reversal of neuromuscular blockade">Next page</a> ►</div></div></div></div><div id="p1"><div id="sideBar"><h2>See Also</h2><ul><li><h3>AHFS Drug Information (2)</h3></li><li><a href="http://www.medicinescomplete.com/mc/ahfs/2010/a382226.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Neostigmine Bromide, Neostigmine Methylsulfate</a><div class="breadcrumb"><p><strong>AHFS Drug Information</strong> &gt; Autonomic Drugs* 12:00 &gt; Parasympathomimetic (Cholinergic) Agents 12:04</p></div></li><li><a href="http://www.medicinescomplete.com/mc/ahfs/2010/a384022.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Glycopyrrolate</a><div class="breadcrumb"><p><strong>AHFS Drug Information</strong> &gt; Autonomic Drugs* 12:00 &gt; Anticholinergic Agents 12:08 &gt; Antimuscarinics/Antispasmodics 12:08.08</p></div></li></ul><ul><li><h3>Stockley's Interaction Alerts (2)</h3></li><li><a href="http://www.medicinescomplete.com/mc/alerts/2010/21835-v.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Glycopyrronium</a><div class="breadcrumb"><p><strong>Stockley's Interaction Alerts</strong> &gt; Interactants: G &gt; Interactions of Glycopyrronium</p></div></li><li><a href="http://www.medicinescomplete.com/mc/alerts/2010/15576-a.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Neostigmine</a><div class="breadcrumb"><p><strong>Stockley's Interaction Alerts</strong> &gt; Interactants: N &gt; Interactions of Neostigmine</p></div></li></ul><ul><li><h3>British National Formulary (15)</h3></li><li><a href="29458.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Miscellaneous conditions</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; Guidance on prescribing &gt; Prescribing in palliative care</p></div></li><li><a href="29476.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Continuous infusion devices</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; Guidance on prescribing &gt; Prescribing in palliative care</p></div></li><li><a href="2206.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">1.6.2 Stimulant laxatives</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 1 Gastro-intestinal system &gt; 1.6 Laxatives</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22neostigmine+with+glycopyrronium+bromide%22%22neostigmine%22%22glycopyrronium+bromide%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (15)</a></li></ul><ul><li><h3>BNF for Children (16)</h3></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/29458.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Miscellaneous conditions</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; General guidance &gt; Prescribing in palliative care</p></div></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/29476.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Continuous infusion devices</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; General guidance &gt; Prescribing in palliative care</p></div></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/5324.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Anticholinesterases</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 10 Musculoskeletal and joint diseases &gt; 10.2 Drugs used in neuromuscular disorders &gt; 10.2.1 Drugs that enhance neuromuscular transmission</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22neostigmine+with+glycopyrronium+bromide%22%22neostigmine%22%22glycopyrronium+bromide%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (16)</a></li></ul><ul><li><h3>Clarke's Analysis of Drugs and Poisons (2)</h3></li><li><a href="http://www.medicinescomplete.com/mc/clarke/2010/CLK0799.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Glycopyrronium Bromide</a><div class="breadcrumb"><p><strong>Clarke's Analysis of Drugs and Poisons</strong> &gt; Monographs &gt; Alphabetically &gt; G</p></div></li><li><a href="http://www.medicinescomplete.com/mc/clarke/2010/CLK1157.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Neostigmine Bromide</a><div class="breadcrumb"><p><strong>Clarke's Analysis of Drugs and Poisons</strong> &gt; Monographs &gt; Alphabetically &gt; N</p></div></li></ul><ul><li><h3>Handbook on Injectable Drugs (2)</h3></li><li><a href="http://www.medicinescomplete.com/mc/hid/2010/a582090.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Glycopyrrolate</a><div class="breadcrumb"><p><strong>Handbook on Injectable Drugs</strong> &gt; Monographs &gt; G</p></div></li><li><a href="http://www.medicinescomplete.com/mc/hid/2010/a582141.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Neostigmine Methylsulfate</a><div class="breadcrumb"><p><strong>Handbook on Injectable Drugs</strong> &gt; Monographs &gt; N</p></div></li></ul><ul><li><h3>Stability-Indicating HPLC Methods for Drug Analysis (2)</h3></li><li><a href="http://www.medicinescomplete.com/mc/hplc/2008/ch0007s0055.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Glycopyrrolate</a><div class="breadcrumb"><p><strong>Stability-Indicating HPLC Methods for Drug Analysis</strong> &gt; Monographs &gt; G</p></div></li><li><a href="http://www.medicinescomplete.com/mc/hplc/2008/ch0013s0112.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Neostigmine Methylsulfate</a><div class="breadcrumb"><p><strong>Stability-Indicating HPLC Methods for Drug Analysis</strong> &gt; Monographs &gt; N</p></div></li></ul><ul><li><h3>Injectable Drugs Guide (2)</h3></li><li><a href="http://www.medicinescomplete.com/mc/idg/2010/G08-mn0001.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Glycopyrronium bromide (glycopyrrolate)</a><div class="breadcrumb"><p><strong>Injectable Drugs Guide</strong> &gt; Injectable Drugs Guide &gt; Monographs &gt; G</p></div></li><li><a href="http://www.medicinescomplete.com/mc/idg/2010/n04-mn0001.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Neostigmine metilsulfate (neostigmine methylsulfate)</a><div class="breadcrumb"><p><strong>Injectable Drugs Guide</strong> &gt; Injectable Drugs Guide &gt; Monographs &gt; N</p></div></li></ul><ul><li><h3>Martindale: The Complete Drug Reference (2)</h3></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/ms-15576-a.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Neostigmine</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Drugs and Ancillary Substances &gt; By therapeutic use &gt; Antimyasthenics &gt; Drug Monographs</p></div></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/371-a.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Glycopyrronium Bromide</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Drugs and Ancillary Substances &gt; By therapeutic use &gt; Miscellaneous Drugs and Other Substances &gt; Drug Monographs</p></div></li></ul><ul><li><h3>The Merck Index (2)</h3></li><li><a href="http://www.medicinescomplete.com/mc/merck/2010/04501.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Glycopyrrolate</a><div class="breadcrumb"><p><strong>The Merck Index</strong> &gt; Monographs &gt; G &gt; GL</p></div></li><li><a href="http://www.medicinescomplete.com/mc/merck/2010/06464.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Neostigmine</a><div class="breadcrumb"><p><strong>The Merck Index</strong> &gt; Monographs &gt; N &gt; NE</p></div></li></ul><ul><li><h3>Stockley's Drug Interactions (2)</h3></li><li><a href="http://www.medicinescomplete.com/mc/stockley/2010/int-E2E0E4E3E0R0D23.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Glycopyrronium</a><div class="breadcrumb"><p><strong>Stockley's Drug Interactions</strong> &gt; Interactants, Alphabetically &gt; G</p></div></li><li><a href="http://www.medicinescomplete.com/mc/stockley/2010/int-E0E0E26E3E0R0D1318.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Neostigmine</a><div class="breadcrumb"><p><strong>Stockley's Drug Interactions</strong> &gt; Interactants, Alphabetically &gt; N</p></div></li></ul><ul><li><h3>Drug Administration via Enteral Feeding Tubes (2)</h3></li><li><a href="http://www.medicinescomplete.com/mc/tubes/2010/c176.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Glycopyrronium bromide</a><div class="breadcrumb"><p><strong>Drug Administration via Enteral Feeding Tubes</strong> &gt; Handbook of Drug Administration via Enteral Feeding Tubes &gt; Monographs &gt; G</p></div></li><li><a href="http://www.medicinescomplete.com/mc/tubes/2010/c402.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Neostigmine</a><div class="breadcrumb"><p><strong>Drug Administration via Enteral Feeding Tubes</strong> &gt; Handbook of Drug Administration via Enteral Feeding Tubes &gt; Monographs &gt; N</p></div></li></ul><script type="text/javascript" src="scripts/sidebar.js"></script></div><div id="pB"><h1 id="_203950">NEOSTIGMINE WITH GLYCOPYRRONIUM BROMIDE</h1><div id="pC" class="jN"><div class="cAJ"><span class="cAD">Additional information</span> interactions (<a href="41001i976.htm" title="Go to appendix 1">Glycopyrronium</a>, <a rel="appendix" href="41001i647.htm" title="Go to appendix 1">Neostigmine</a>).</div><div class="cAF"><h2>Indications</h2> <p class="cAF">see under Dose</p></div><div class="cAF"><h2>Cautions</h2> <p class="cAF">bronchospasm; severe bradycardia; coronary artery disease; congestive heart failure; arrhythmias; hyperthyroidism; hypertension; pyrexia; epilepsy; parkinsonism; susceptibility to angle-closure glaucoma; <b>interactions:</b> Appendix 1 (parasympathomimetics,
antimuscarinics)</p></div><div class="cAF"><h2>Contra-indications</h2> <p class="cAF">intestinal or urinary obstruction</p></div><div class="cAF"><h2>Renal impairment</h2> <p class="cAF">may need dose reduction</p></div><div class="cAF"><h2>Pregnancy</h2> <p class="cAF">safety not established—limited information available</p></div><div class="cAF"><h2>Breast-feeding</h2> <p class="cAF">no information available</p></div><div class="cAF"><h2>Side-effects</h2> <p class="cAF">nausea, vomiting, changes in salivation, diarrhoea;
transient bradycardia (followed by tachycardia, palpitation, and arrhythmias);
changes in bronchial secretions; urinary urgency and retention; dilatation
of the pupils with loss of accommodation; <i>very rarely</i> angle-closure glaucoma; <i>signs of overdosage with neostigmine</i> include bronchoconstriction, increased bronchial secretions, lacrimation,
excessive sweating, involuntary defaecation and micturition, miosis,
nystagmus, bradycardia, heart block, arrhythmias, hypotension, agitation,
excessive dreaming, and weakness (leading to fasciculation and paralysis)</p></div><div class="cAF"><h2>Dose</h2> <p class="cR">See under preparation</p></div></div><?highlighter on?><div id="pS"><p>Sub-sections</p><ul class="jT"><li class="jN" id="_203951" style="margin: 0 0 0 20px;"><h1 class="title">Glycopyrronium–Neostigmine<span> (Non-proprietary)</span> <img class="cJ" src="images/pom_l.png" title="Prescription-only Medicine" alt="Prescription-only Medicine" /></h1><div class="cAY"><span class="cAB">Injection</span>, neostigmine metilsulfate
2.5 mg, glycopyrronium bromide 500 micrograms/mL, net price 1-mL amp
= 91p<div class="cAQ"><div class="cAF"><h2>Dose</h2> <p class="cAF">reversal of non-depolarising neuromuscular blockade, <span class="cU">by intravenous injection</span> over 10–30 seconds, 1–2 mL <i>or</i> 0.02 mL/kg, dose may be repeated if required (total max.
2 mL); <span class="cAK">child</span> 0.02 mL/kg (or 0.2 mL/kg
of a 1 in 10 dilution using water for injections or sodium chloride
injection 0.9%), dose may be repeated if required (total max. 2 mL)</p></div></div></div></li></ul></div><?highlighter off?><div id="pE">◄ <a accesskey="[" href="6669.htm">Previous: NEOSTIGMINE METILSULFATE</a> | <a class="top" href="203951.htm#">Top</a> | <a accesskey="]" href="201173.htm">Next: Other drugs for reversal of neuromuscular blockade</a> ►</div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Privacy Policy">Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="35091.htm" rel="copyright">Copyright © BMJ Group and the Royal Pharmaceutical Society of Great Britain 2012. All rights reserved.</a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>